Correlation of Aberrant Methylation of APC Gene to MTHFR C677T Genetic Polymorphisms in Hepatic Carcinoma

  • Lian-Hua Cui
  • Meng Liu
  • Hong-Zong Si
  • Min-Ho Shin
  • Hee Nam Kim
  • Jin-Su Choi
Conference paper
Part of the Lecture Notes in Electrical Engineering book series (LNEE, volume 269)


Object To investigate the relationship between aberrant hypermethylation of APC gene and methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphisms in Hepatic Carcinoma. Method Hepatic Carcinoma cancer tissues and para-cancerous normal tissues were collected. CpG island methylation status of APC gene and MTHFR gene polymorphisms were analyzed by Real-time quantitative polymerase chain reaction (Real-time PCR). The associations between methylation status of APC gene and clinical characteristics, as well as the relationship between APC methylation and MTHFR C677T polymorphisms, were evaluated. Results Among 86 HCC patients, the aberrant hypermethylation rate of APC gene in tumorous tissues (77.9 %) was significantly higher than that in para-cancerous normal tissues (46.5 %). No relationship was found between APC gene methylation and selected factors including sex, age, tumor size, TNM stage, HBsAg and AFP. After adjustment for potential confounders, individuals carrying MTHFR 677 T allele gene have higher frequency of hypermethylation in APC gene in cancer tissues, with odds ratio of 3.64(95 % CI: 1.13–11.79). Our results suggested that MTHFR 677 T allele might be associated with aberrant methylation of APC gene.


APC methylation MTHFR gene polymorphism Hepatic carcinoma 



This work was supported, in part, by the National Natural Science Foundation of China (Contract No. 30872169) and the Natural Science Foundation of China (Contract No. ZR2011HM031).


  1. 1.
    Laird PW, Jaenisch R (1996) The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 30:441–464CrossRefGoogle Scholar
  2. 2.
    Baylin SB (2005) DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2(Suppl 1):S4–11CrossRefGoogle Scholar
  3. 3.
    Baoxing FKZ, Dechang W (2002) DNA methylation and tumor. Foreign Med Mole Biol 24(3):139–143Google Scholar
  4. 4.
    Graziano F, Kawakami K, Ruzzo A et al (2006) Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer J Int Du Cancer 118(3):628–632CrossRefGoogle Scholar
  5. 5.
    Wang J, Sasco AJ, Fu C et al (2008) Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomark Prev 17(1):118–125CrossRefGoogle Scholar
  6. 6.
    Kim HN, Lee IK, Kim YK et al (2008) Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 140(3):287–294CrossRefGoogle Scholar
  7. 7.
    Bárbara do Nascimento Borges RMRB MLH (2013) Analysis of the methylation patterns of the p16INK4A, p15INK4B, and APC genes in gastric adenocarcinoma patients from a Brazilian population. Tumor Biol doi: 101007/s13277-013-0742-yGoogle Scholar
  8. 8.
    Kondo Y, Kanai Y, Sakamoto M et al (2000) Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis–A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 32(5):970–979CrossRefGoogle Scholar
  9. 9.
    Deng G, Song GA, Pong E et al (2004) Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor. Cancer Res 64(8):2692–2698CrossRefGoogle Scholar
  10. 10.
    Yoon HY, Kim YW, Kang HW et al (2013) Pyrosequencing analysis of APC methylation level in human prostate tissues: a molecular marker for prostate cancer. Korean J Urol 54(3):194–198CrossRefGoogle Scholar
  11. 11.
    Tserga AMN, Levidou G, Korkolopoulou P et al (2012) Association of aberrant DNA methylation with clinicopathological features in breast cancer. Oncol Reports 27(5):1630–1638Google Scholar
  12. 12.
    Begum S, Brait M, Dasgupta S et al (2011) An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 17(13):4494–4503CrossRefGoogle Scholar
  13. 13.
    Kang HJ, Kim EJ, Kim BG et al (2012) Quantitative analysis of cancer-associated gene methylation connected to risk factors in Korean colorectal cancer patients. J Prev Med Public Health 45:251–258Google Scholar
  14. 14.
    Feng Q, Stern JE, Hawes SE et al (2010) DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection. Exp Mol Pathol 88(2):287–292CrossRefGoogle Scholar
  15. 15.
    Hua D, Hu Y, Wu YY et al (2011) Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma. Exp Mol Pathol 91:455–460CrossRefGoogle Scholar
  16. 16.
    Iyer P, Zekri AR, Hung CW et al (2010) Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients. Exp Mol Pathol 88(1):107–111CrossRefGoogle Scholar
  17. 17.
    Yu J, Ni M, Xu J et al (2002) Methylation Profiling of twenty Promoter CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 29(2):1–14MATHGoogle Scholar
  18. 18.
    Gao S, Ding LH, Wang JW et al (2013) Diet folate, DNA methylation and polymorphisms in Methylenetetrahydrofolate reductase in association with the susceptibility to gastric cancer. Asian Pacific J Cancer Prev 14(1):299–302CrossRefGoogle Scholar
  19. 19.
    Zhao P, Lin F, Li Z et al (2011) Folate Intake, Methylenetetrahydrofolate Reductase Polymorphisms, and Risk of Esophageal Cancer. Asian Pac J Cancer Prev 12:2019–2023Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Lian-Hua Cui
    • 1
  • Meng Liu
    • 1
  • Hong-Zong Si
    • 2
  • Min-Ho Shin
    • 3
  • Hee Nam Kim
    • 4
  • Jin-Su Choi
    • 3
  1. 1.Department of Public HealthQingdao UniversityQingdaoChina
  2. 2.Institute for Computational Science and Engineering, the Growing Base for State Key LaboratoryQingdao UniversityQingdaoChina
  3. 3.Department of Preventive MedicineChonnam National University Medical SchoolGwangjuSouth Korea
  4. 4.Genome Research Center for Hematopoietic DiseasesChonnam National University Hwasun HospitalHwasunSouth Korea

Personalised recommendations